|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-3-10
|
|
pubmed:abstractText |
Breast angiosarcoma is rare and often associated with previous breast cancer treatment. The present study aimed to define long-term outcomes in relation to common prognostic factors. The expression of vascular endothelial growth factor receptor was also evaluated, as it may be a potential target for anti-angiogenic therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
930-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21388054-Angiogenesis Inhibitors,
pubmed-meshheading:21388054-Breast Neoplasms,
pubmed-meshheading:21388054-Disease-Free Survival,
pubmed-meshheading:21388054-Female,
pubmed-meshheading:21388054-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21388054-Hemangiosarcoma,
pubmed-meshheading:21388054-Humans,
pubmed-meshheading:21388054-Male,
pubmed-meshheading:21388054-Mastectomy, Segmental,
pubmed-meshheading:21388054-Middle Aged,
pubmed-meshheading:21388054-Neoplasms, Second Primary,
pubmed-meshheading:21388054-Radiotherapy, Adjuvant,
pubmed-meshheading:21388054-Receptors, Vascular Endothelial Growth Factor,
pubmed-meshheading:21388054-Retrospective Studies,
pubmed-meshheading:21388054-Treatment Outcome
|
|
pubmed:articleTitle |
Angiosarcoma of the breast and vascular endothelial growth factor receptor.
|
|
pubmed:affiliation |
Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. massimiliano.gennaro@istitutotumori.mi.it
|
|
pubmed:publicationType |
Journal Article
|
